Richard Weaver

WORK HISTORY

EDUCATION

SKILLS

ABOUT RICHARD WEAVER

PROFILE & OVERVIEWFounder and Managing Director of Drug Discovery Solutions Limited.Previously CEO and founder of XenoGesis Limited in 2011. Led the successful sale to Sygnature Discovery in September 2020. Both a current scientist and businessman, with a keen eye to understand and lead the successful development of people and company ROI.Strategically energetic and entrepreneurial with a continuous drive to improve and offer help and advice in both science and business.Very highly motivated, enjoy problem solving and thrive on challenges.Expert knowledge and experience (26 years) of all aspects of R&D including Due Diligence of companies/assets. Specialist in Drug Metabolism & Pharmacokinetics (DMPK) from Hit Identification (HI) to Candidate Drug (CD) nomination and pre-clinical development.A successful track record of identifying project and people issues and resolving them.Educated as a chemist to postdoctoral level with the best performance prize at all years as an undergraduate. Coupling my in depth chemistry knowledge with extensive DMPK and general R&D experience, creates a powerful platform to succeed in an R&D environment.My future ambitions are:(1) To influence and enhance the success rate of pre-clinical candidates in order to maximise human health and patient benefit(2) To build the business that maximises profitability, growth, employment, shareholder value and ultimate ROI.(3) Lead, motivate and develop staff and teams to their best potential.Specialities: Entrepreneur and Biotech CRO business founder. Grown XenoGesis from zero to £3.8 million turnover in 9 years, purely by organic growth and reinvestment.